@article{article, title = {{A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial}}, publisher = {{Elsevier}}, url = {{http://eprints.whiterose.ac.uk/163844/ }}, year = {{2020}}, month = {{6}}, author = {{Peters S and Danson S and Hasan B and Dafni U and Reinmuth N and Majem M and Tournoy KG and Mark MT and Pless M and Cobo M and Rodriguez-Abreu D et al}}, doi = {{10.1016/j.jtho.2020.06.011}}, journal = {{Journal of Thoracic Oncology}}, note = {{Accessed on 2025/05/06}}}